Moderna (MRNA) Enterprise Value (2018 - 2026)
Moderna's Enterprise Value came in at $22.8 billion for Q2 2026, up 307.1% from $5.6 billion a year earlier and up 52.4% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Enterprise Value (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Moderna reported Enterprise Value of $7.3 billion; for FY2025, it was $5.82 billion, down 35.5% from FY2024.
- Enterprise Value has declined in each of the last four years, with a five-year compound annual growth rate of -30.9% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $9.02 billion in FY2024 (-69.3%), $29.39 billion in FY2023 (-50.4%), $59.25 billion in FY2022 (-35.3%) and $91.63 billion in FY2021 (+147.1%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q2 2024.
- Year-over-year, Enterprise Value increased in two of the last eight quarters, with growth averaging 15.2%.
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2021 (growth of 495.1%), and the weakest in Q2 2025 (a decline of 84.9%).
- Business Quant data shows MRNA's Enterprise Value at $14.96 billion (Q1 2026), $5.82 billion (Q4 2025) and $5.6 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.80 Bn |
| Mar 31, 2026 | 14.96 Bn |
| Dec 31, 2025 | 5.82 Bn |
| Sep 30, 2025 | 5.60 Bn |
| Jun 30, 2025 | 5.60 Bn |
| Mar 31, 2025 | 5.00 Bn |
| Dec 31, 2024 | 9.02 Bn |
| Sep 30, 2024 | 18.86 Bn |
| Jun 30, 2024 | 37.11 Bn |
| Mar 31, 2024 | 32.29 Bn |
| Dec 31, 2023 | 29.39 Bn |
| Sep 30, 2023 | 31.78 Bn |
| Jun 30, 2023 | 37.83 Bn |
| Mar 31, 2023 | 50.05 Bn |
| Dec 31, 2022 | 59.25 Bn |
| Sep 30, 2022 | 37.41 Bn |
| Jun 30, 2022 | 48.10 Bn |
| Mar 31, 2022 | 58.79 Bn |
| Dec 31, 2021 | 91.63 Bn |
| Sep 30, 2021 | 146.96 Bn |
API Access
Moderna Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();